FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely, pulmonology, and can be used in the treatment or prevention of lung diseases. Invention relates to a composition comprising ectoin, hydroxyectoin and/or a salt of these compounds. Combination drug contains compositions for simultaneous administration.
EFFECT: use of inventions allows to treat inflammation in the lung tissue by restoring a normal degree of apoptosis.
9 cl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITION | 2017 |
|
RU2749723C2 |
| USE OF TERPENE COMPOUNDS FOR DECREASED RELEASE OF ARACHIDONIC ACIDS AND MEDIATORS OF INFLAMMATION | 1994 |
|
RU2161482C2 |
| COMBINATION OF R,R-GLYCOPYRROLATE AND MONTELUKAST FOR TREATMENT OF RESPIRATORY DISEASES AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2420285C2 |
| PROTECTIVE AND REGENERATING COMPOSITION | 2007 |
|
RU2420265C2 |
| COMPOSITIONS BASED ON CYCLODEXTRIN AND A BUDESONIDE DERIVATIVE AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2722414C2 |
| 7-AZAINDOLES, THEIR USING AS INHIBITORS OF PHOSPHODIESTERASE 4 AND METHOD FOR THEIR PREPARING | 2001 |
|
RU2268887C2 |
| 7-AZAINDOLES AND THEIR USE AS MEDICINAL AGENTS | 2004 |
|
RU2349592C2 |
| CD89 ACTIVATION IN THERAPY | 2011 |
|
RU2640082C2 |
| METHODS OF DEPRESSING INFLAMMATION MEDIATOR RELEASE AND PEPTIDES APPLIED FOR THIS PURPOSE | 2007 |
|
RU2423376C2 |
| STABLE COMPOSITIONS OF ASCORBIC ACID AND METHODS OF THEIR USE | 2018 |
|
RU2799046C2 |
